FDA Import Refusal 799-2186088-9/11/1 — UCB Pharma S.A.
The FDA refused shipment 799-2186088-9/11/1 from UCB Pharma S.A. (Belgium) on Jul 23, 2024. The refused product falls under Drugs and Biologics — CERTOLIZUMAB PEGOL. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 23, 2024
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 58SCY06 CERTOLIZUMAB PEGOL
- Charges
- 75